| Updated in 11/7/2019 10:25:32 AM |
Viewed: 247 times |
(Journal Article) |
Journal of the National Comprehensive Cancer Network : JNCCN 12 (11): 1517-23 (2014)
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.
Louis Burt Nabors
,
Jana Portnow
,
Mario Ammirati
,
Henry Brem
,
Paul Brown
,
Nicholas Butowski
,
Marc C Chamberlain
,
Lisa M DeAngelis
,
Robert A Fenstermaker
,
Allan Friedman
,
Mark R Gilbert
,
Jona Hattangadi-Gluth
,
Deneen Hesser
,
Matthias Holdhoff
,
Larry Junck
,
Ronald Lawson
,
Jay S Loeffler
,
Paul L Moots
,
Maciej M Mrugala
,
Herbert B Newton
,
Jeffrey J Raizer
,
Lawrence Recht
,
Nicole Shonka
,
Dennis C Shrieve
,
Allen K Sills
,
Lode J Swinnen
,
David Tran
,
Nam Tran
,
Frank D Vrionis
,
Patrick Yung Wen
,
Nicole R McMillian
,
Maria Ho
ABSTRACT
The NCCN Guidelines for Central Nervous System Cancers provide multidisciplinary recommendations for the clinical management of patients with cancers of the central nervous system. These NCCN Guidelines Insights highlight recent updates regarding the management of metastatic brain tumors using radiation therapy. Use of stereotactic radiosurgery (SRS) is no longer limited to patients with 3 or fewer lesions, because data suggest that total disease burden, rather than number of lesions, is predictive of survival benefits associated with the technique. SRS is increasingly becoming an integral part of management of patients with controlled, low-volume brain metastases.